Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

Brainshake Ltd.. (9/14/16). "Press Release: Brainshake Closes €3.5m to Advance Regulatory Approval of Blood Analysis Service". Helsinki.

Organisations Organisation Brainshake Ltd. (FI)
  Organisation 2 Cor Group (FI)
Products Product NMR spectroscopy
  Product 2 metabolomic services
Index term Index term Brainshake–SEVERAL: investment, 201607 financing round Series A €3.5m led by Cor Group + incl Tekes + Nordea + Finnvera
     


Finnish Brainshake has raised 3.5 million euros in Series A funding. The investment will be used to advance regulatory approval and internationalization of its blood analysis service.

Brainshake’s blood analysis service provides more than 220 biomarkers from a single blood sample – 50 times more than commonly used laboratory methods. Biomarkers reflect the health state of an individual and can be used to predict disease risk in chronic diseases. Brainshake’s blood analysis, backed up by 100 peer-reviewed scientific publications, is used by leading universities globally.

“Our technology has been proven by peer-reviewed science and the epidemiological studies show the power of our data in risk assessment of chronic diseases. Now we are bringing the technology to routine healthcare with the ultimate target to enable prevention of the world’s number one health problem”, says Teemu Suna , CEO, Brainshake.

The 3.5 million investment is led by Cor Group, a Finnish growth venture, joining Brainshake as a shareholder and long-term strategic partner. Other parties of the financial package include Tekes, Nordea and Finnvera. Brainshake is also a member of one of the world’s biggest health-focused start-up accelerators StartUp Health.

“We have worked in the global healthcare market for nearly 30 years, and consider Brainshake’s blood analysis highly impressive. We look forward to working together to create a global market leader and to advance the company’s mission to transform preventive medicine in chronic diseases together with our Group. Our goal is to work with Brainshake as a long-term strategic partner, an active member of the board and co-owner”, says Olli Karhi , board member, Cor Group.

Helsinki-based Brainshake has 15 employees in Finland. In 2015, the company’s turnover was 1,6 million euros.


Further information:

Teemu Suna, CEO, Brainshake, tel. +358 40 196 1669, teemu.suna@brainshake.fi


About Brainshake

Brainshake Ltd. is a blood analysis company redesigning global healthcare through the power of metabolic profiling. With technology backed up by 100 peer-reviewed biomedical publications, Brainshake provides disruptive blood analysis service to advance precision medicine in chronic diseases. For more information please visit www.brainshake.fi .

Contacts

Kristiina Tolvanen
Content Manager

Teknobulevardi 3-5 01530 Vantaa, FINLAND
+358 40 755 2468
http://www.brainshake.fi
kristiina.tolvanen@brainshake.fi

   
Record changed: 2016-10-10

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px

More documents for Brainshake Ltd. (FI)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px